(Q58053853)

English

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

article

In more languages

Statements

scholarly article

0 references

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis (English)

0 references

papillary thyroid cancer

1 reference

based on heuristic

inferred from title

Raffaele Ciampi

object named as

Raffaele Ciampi

8

0 references

Gerard M Doherty

object named as

Gerard Doherty

12

0 references

Thomas Giordano

object named as

Thomas J Giordano

1

0 references

author name string

Rork Kuick

2

0 references

Dafydd G Thomas

3

0 references

David E Misek

4

0 references

Michelle Vinco

5

0 references

Donita Sanders

6

0 references

Zhaowen Zhu

7

0 references

Michael Roh

9

0 references

Kerby Shedden

10

0 references

Paul Gauger

11

0 references

Norman W Thompson

13

0 references

Samir Hanash

14

0 references

Ronald J Koenig

15

0 references

Yuri E Nikiforov

16

0 references

language of work or name

0 references

publication date

27 June 2005

0 references

0 references

24

0 references

44

0 references

6646-6656

0 references

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208822

0 references

Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

The genetics and genomics of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Identification and validation of an ERBB2 gene expression signature in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Profiling cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Natural history, treatment, and course of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Silencing of thePTENtumor-suppressor gene in anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Anaplastic thyroid carcinoma: current diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

B-RAF is a therapeutic target in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Well differentiated thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Design and discovery of small molecules targeting raf-1 kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Looking beyond morphology: cancer gene expression profiling using DNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Discovery of a novel Raf kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Molecular pathogenesis of thyroid nodules and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

RET/PTC rearrangement in thyroid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Opportunities and challenges in the development of kinase inhibitor therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Molecular pathogenesis of thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Thyroid peroxidase expression and DNA polymorphisms in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Asymptotics for and against cross-validation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

21 January 2018

The molecular basis of thyroid epithelial tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

c‐Met expression in tall cell variant papillary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Tall cell variant: an aggressive form of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208822

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1208822

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58053853&oldid=1779671727"